CCMW
IDXX icon

Cypress Capital Management (Wyoming)’s Idexx Laboratories IDXX Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9
Closed -$2K – 303
2018
Q4 		$2K Buy
+9
New +$1.84K ﹤0.01% 295

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s IDXX Position: Q1 2019 in Review

Cypress Capital Management (Wyoming) sold out of Idexx Laboratories (IDXX) in Q1 2019, closing a stake of 9 shares — an estimated $2K sold.

Cypress Capital Management (Wyoming) first reported a position in IDXX in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 685 funds tracked by Wall St. Rank hold IDXX as of Q1 2019.

  • Cypress Capital Management (Wyoming) reported no remaining Idexx Laboratories position as of Q1 2019 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 9 Idexx Laboratories shares in Q1 2019, an estimated $2K.
  • Cypress Capital Management (Wyoming) first reported a position in Idexx Laboratories in Q4 2018 and held it in 1 quarter.
  • Cypress Capital Management (Wyoming)'s Idexx Laboratories position peaked at $2K in Q4 2018.
  • 685 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2019.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2019, filed 6 May 2019.